JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 24 filers reported holding JASPER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,963,754 | -48.9% | 8,519,648 | 0.0% | 7.92% | -35.4% |
| Q2 2023 | $11,671,918 | -24.3% | 8,519,648 | 0.0% | 12.26% | -34.3% |
| Q1 2023 | $15,420,563 | +445.6% | 8,519,648 | +45.6% | 18.66% | +399.1% |
| Q4 2022 | $2,826,405 | -38.8% | 5,852,982 | 0.0% | 3.74% | -44.3% |
| Q3 2022 | $4,619,000 | -59.1% | 5,852,982 | 0.0% | 6.71% | -57.2% |
| Q2 2022 | $11,296,000 | -45.6% | 5,852,982 | 0.0% | 15.68% | -19.7% |
| Q1 2022 | $20,778,000 | -54.8% | 5,852,982 | 0.0% | 19.52% | -7.7% |
| Q4 2021 | $45,946,000 | – | 5,852,982 | – | 21.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 5,852,982 | $20,778,000 | 19.52% |
| Velan Capital Investment Management LP | 3,219,036 | $10,180,000 | 9.45% |
| Abingworth LLP | 5,628,558 | $19,531,000 | 5.54% |
| SECTORAL ASSET MANAGEMENT INC | 675,000 | $2,396,000 | 0.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 540,000 | $1,917,000 | 0.20% |
| Vahanian & Associates Financial Planning Inc. | 10,000 | $36,000 | 0.08% |
| Forefront Analytics, LLC | 32,550 | $118,000 | 0.04% |
| Citadel Advisors | 2,994,580 | $10,631,000 | 0.00% |
| FEDERATED HERMES, INC. | 251,697 | $894,000 | 0.00% |
| Ionic Capital Management LLC | 100 | $0 | 0.00% |